Austin D, Kristinsson K, and R Anderson. The relationship between the volume of antimicrobial consumption in human communities and the frequency of resistance. Proceeding of the National Academy of Sciences. 1999. 96: 1152-1156. Barker K. Antibiotic resistance: A current perspective. Journal of Clinical Pharmacology. 1999. 48: 109-124.

Bjorkman J, Hughes D, and Andersson D. Virulence of antibiotic resistant Salmonella typhimurium. Proceeding of The National Academy of Sciences. 1998. 95: 3949-3953.

Blahova J, Kralikova K, Kremery V, and A. Mikovicova. High-frequency transduction of resistance to ceftazidime an other antibiotics by a wild-type Pseudomonas aeruginosa phage. International Journal of Medical Microbiology. 1999. 289: 179-183.

Campbell N. 1996. Biology, 4th ed. Benjamin/Cumminings: New York.

Caputo G, Appelbaum P, and H Liu. Infections due to penicillin-resistant pneumococci. Archives of Internal Medicine. 1993. 153: 1301-1310.

CDC. Reduced susceptibility of Staphylococcus aureus to Vancomycin. MMWR. 1997. 46: 627-626.

CDC. Staphylococcus aureus. MMWR. 2000. 48: 1165-1167.

CDC. MRSA. 2000. Available URL: www.cdc.gov./ncidod/hip/areesist/mrsafaq.html.

Clifford L, Kuehnert M, Tenover F, and W Jarvis. Vancomycin-resistant enterococci outside the health care setting: Prevalence, sources and public health implication. Emerging Infectious Diseases. 1997. Available URL: www.cdc.gov./ncidod/eid/vol3no3mcdonald.html

Cohen M. Epidemiology of drug resistance: implications for a post-antimicrobial era. Science. 1992. 257: 1050-1055.

Cristino J. Correlation between consumption of antimicrobials in humans and development of resistance in bacteria. International Journal of Antimicrobial Agents. 1999. 12: 199-202.

Davies J. What are antibiotics? Archaic functions for modern activities. Molecular Microbiology. 1990. 4: 1227-1232.

Ewald P. 2000. Plague Time. Free Press: New York.

Finegold S. Antimicrobial therapy of anaerobic infections: A status report. Hospital Practice. 1979. 23: 71-81.

Flore K. Fighting a new war on drugs. Michigan Health & Hospitals Magazine. 2000. May/June: 22-23.

Garcia-Bustos J and A. Tomasz. A biological price of antibiotic resistance: Major changes in the peptidoglycan structure of penicillin-resistant pneumococci. Proceedings of the National Academy of Sciences. 1990. 87: 5415-5419.

Garrett L. The Coming Plague: Newly emerging diseases in a world out of balance. 1994. Penguin Books: New York.

Gentry L. Bacterial resistance. Orthopedic Clinics of North America. 1991. 22: 379-388.
Gould I. A review of the role of antibiotic policies in control of antibiotic resistance. Journal of Antimicrobial Chemotherapy. 1999. 43: 459-465.

Griffiths A, Gelbart W, Miller J, and R Lewontin. 1999. Modern Genetic Analysis. W.H. Freeman and Company: New York.

Huycke M, Sahm D, and M Gilmore. Multple-drug resistant enterococci: The nature of the problem and an agenda for the future. Emerging Infectious Diseases. 1998. Available URL: www.cdc.gov/nicdod/ied.vol4no2/huycke.html.

Janeway C, Travers P, and M Walport. 1999. Immunobiology, 4th ed. Current Biology Publications: New York.

Koplan J. Statement before the U.S. Senate Committee on Appropriations. September 20, 2000.

Lappe M. Breakout: The evolving threat of drug-resistant disease. 1995. Sierra Club Books: San Francisco.

Levy S. The Antibiotic Paradox: How miracle drugs are destroying the miracle. 1992. Plenum Press: New York.

Levy S. The challenge of antibiotic resistance. Scientific American. 1998. 3: 74-83.

Lipsitch M, Bergstrom C and B. Levin. The epidemiology of antibiotic resistance in hospitals: Paradoxes and prescriptions. Proceedings of the National Academy of Sciences. 2000. 97: 1983-1988.

Mazel D and J Davies. Antibiotic resistance in microbes. Cellular and Molecular Life Sciences. 1999. 56: 742-754.

Mouz N, Gordon E, GuilmiA, Petit I, Petillots. Identification of a structural determinant for resistance to ß-lactam antibiotics in gram-positive bacteria. Proceedings of the National Academy of Sciences. 1998. 95: 13403-13406.

Murray B. The life and times of enterococcus. Clinical Microbiology Reviews. 1990. 3: 46-65.

Murray B. Diversity among multidrug-resistant enterococci. Emerging Infectious Diseases. 1998. Available URL: www.cdc.gov/ncidod/eid/vol4nol/murray.html.

Nesse R and G Williams. 1995. Why We Get Sick: The new science of Darwinian Medicine. Random House: New York.

Neu H. The crisis of antibiotic resistance. Science. 1992. 257: 1064-1073.

Olsen H. Antimicrobial resistance with a focus on oral beta-lactamases. European Journal of Oral Sciences. 2000. 108: 163-176.

Panlilio A, Culver D, Gaynes R, Banerjee S, Henderson T, Tolson J. Methicillin-resistant Staphylococcus aureus in U.S. hospitals, 1975-1991. Infection Control and Hospital Epidemiology. 1992. 13: 582-586.

Phillips I. The subtleties of antibiotic resistance. Journal of Antimicrobial Chemotherapy. 1998. 42: 5-12.

Radetsky P. The last days of the wonder drugs. Discover. 1998. 19: 67-75.

Udo E and W Grubb. Transfer of resistance determinant from a multi-resistant Staphylococcus aureus isolate. Journal of Medical Microbiology. 1991. 35: 72-79.

Ziebuhr W, Ohlsen K, Karch H, Korhonen T, and J Hacker. Evolution of bacterial pathogenesis. Cellular and Molecular Life Sciences. 1999. 56: 719-728.